BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20551577)

  • 1. Ceftriaxone resistance in Salmonella Typhi - myth or a reality!
    Sabharwal ER
    Indian J Pathol Microbiol; 2010; 53(2):389. PubMed ID: 20551577
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual Salmonella typhi infection.
    Adhikary R; Joshi S
    Indian J Pathol Microbiol; 2011; 54(4):849-50. PubMed ID: 22234135
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinolone-resistant Salmonella enterica Serovar typhi presenting as acute fulminant hepatitis.
    Mitra S; Karthik R; Balaji V; George IA; Kapil A; Abraham OC
    J Assoc Physicians India; 2009 Apr; 57():338-9. PubMed ID: 19702041
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone.
    Nath G; Maurya P
    Int J Antimicrob Agents; 2010 May; 35(5):482-5. PubMed ID: 20188522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmonella typhiin the past decade: learning to live with resistance.
    Rodrigues C; Mehta A; Joshi VR
    Clin Infect Dis; 2002 Jan; 34(1):126. PubMed ID: 11731956
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
    Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
    J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance in Salmonella enterica serotype Typhi isolated from chronic typhoid carriers.
    Pratap CB; Patel SK; Shukla VK; Tripathi SK; Singh TB; Nath G
    Int J Antimicrob Agents; 2012 Sep; 40(3):279-80. PubMed ID: 22789724
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial resistance of Salmonella enterica serotype Typhi in Dakar, Senegal.
    Dromigny JA; Perrier-Gros-Claude JD
    Clin Infect Dis; 2003 Aug; 37(3):465-6. PubMed ID: 12884182
    [No Abstract]   [Full Text] [Related]  

  • 9. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.
    Gupta V; Kaur J; Kaistha N
    Trop Doct; 2009 Jan; 39(1):28-30. PubMed ID: 19211419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries.
    Chuang CH; Su LH; Perera J; Carlos C; Tan BH; Kumarasinghe G; So T; VAN PH; Chongthaleong A; Hsueh PR; Liu JW; Song JH; Chiu CH
    Epidemiol Infect; 2009 Feb; 137(2):266-9. PubMed ID: 18474127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistant Salmonella typhi in Rourkela, Orissa.
    Das U; Bhattacharya SS
    Indian J Pathol Microbiol; 2000 Apr; 43(2):135-8. PubMed ID: 11217269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Salmonella Paratyphi A enteric fever and changing trends in antimicrobial resistance pattern of salmonella in Shimla.
    Verma S; Thakur S; Kanga A; Singh G; Gupta P
    Indian J Med Microbiol; 2010; 28(1):51-3. PubMed ID: 20061765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin--an emerging problem in Bangladesh.
    Rahman MM; Haq JA; Morshed MA; Rahman MA
    Int J Antimicrob Agents; 2005 Apr; 25(4):345-6. PubMed ID: 15784317
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidrug-resistant Salmonella enterica serovar typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh.
    Ahmed D; D'Costa LT; Alam K; Nair GB; Hossain MA
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3516-7. PubMed ID: 17005846
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibiotic sensitivity of Salmonella typhi].
    Buil C; Montes M; Gómez N; López-Lopategui C; Pérez-Trallero E
    Enferm Infecc Microbiol Clin; 1991 Nov; 9(9):582-3. PubMed ID: 1822714
    [No Abstract]   [Full Text] [Related]  

  • 16. A need to revise ciprofloxacin breakpoints for Salmonella in human beings.
    Gupta V; Kaur J
    Int J Infect Dis; 2008 Nov; 12(6):e143-4. PubMed ID: 18514007
    [No Abstract]   [Full Text] [Related]  

  • 17. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai.
    Krishnan P; Stalin M; Balasubramanian S
    Indian J Pathol Microbiol; 2009; 52(4):505-8. PubMed ID: 19805957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.
    Kasper MR; Sokhal B; Blair PJ; Wierzba TF; Putnam SD
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):207-9. PubMed ID: 19800753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ofloxacin--a possible breakthrough in the treatment of typhoid fever caused by chloramphenicol resistant Salmonella typhi.
    Hannan A; Ahmed SA; Akhtar MA; Anwar CM; Mahmood S; Kaleem M; Iqbal M
    J Chemother; 1989 Jul; 1(4 Suppl):383-5. PubMed ID: 16312451
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial resistance pattern of Salmonella typhi isolates in Kolkata, India during 1991-2001: a retrospective study.
    Mandal S; Mandal MD; Pal NK
    Jpn J Infect Dis; 2002 Apr; 55(2):58-9. PubMed ID: 12082312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.